Research & History
Current scientific research, clinical trials, historical context, and the evolving understanding of psilocybin.
25 articles available
Start Here
What is Psilocybin?
The science of psilocybin: from neuroscience to clinical trials at Johns Hopkins and NYU.
8 minWhat is DMT?
DMT research, neuroscience findings, and the history of psychedelic science.
10 minWhat is Microdosing?
Current research on sub-perceptual dosing and emerging scientific evidence.
9 minHistory of Psychedelics
From ancient ritual use to modern clinical research — the full timeline of psychedelic history.
12 minPsychedelic Research Landscape
Clinical trials, FDA designations, major institutions, and how to read studies.
16 minWhat is LSD?
History, pharmacology, neuroscience, and clinical research on lysergic acid diethylamide.
14 minIndigenous & Traditional Use
Sacred traditions spanning thousands of years and the ethics of reciprocity.
14 minMycology Fundamentals
Fungi science, life cycle, taxonomy, and psilocybin biosynthesis.
14 minRelated Journal Articles
Robert Rush: Emergency Scheduling, 7-OH, and the War on Research
Attorney Robert Rush joins Joe in Breckenridge to talk about challenging DEA scheduling decisions, from the 2024 DOI and DOC hearing to the emergency scheduling of 7-OH compounds and SR-17018.
We Played Timothy Leary's 1985 Video Game So You Don't Have To
Neşe, Mike, and Normie play and review "Timothy Leary's Mind Mirror," a 1985 video game originally released for Atari 8-bit and later ported to platforms like the Commodore 64 and Apple II.
The Problems We Will Be Lucky to Have
In November 2020, Oregon voters passed the first ballot measure in the country to create a legal, supervised psilocybin program, Measure 109.
Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic Care Has the Field Asking, and What To Do About It
Colorado did something genuinely special. Oregon launched the country’s first regulated psilocybin program; Colorado was the first to pair one with statewide decriminalization for personal use.
Usona Files Psilocybin for Depression NDA as Race With Compass Tightens
Nonprofit psychedelic research organisation Usona Institute has completed its submission of a new drug application (NDA) to the U.S.
A Medicalization-Only Model Limits the Psychedelic Experience
Psychedelics have been deeply boxed into a container that seems like the acceptable way that they can be talked about.
Australian Bush Doofs and Psychedelic Commercialization (w/ Dr. Sam Douglas & Rich Haridy)
Russell, Mike, and Neşe sit down with journalist Rich Haridy and Dr. Samuel Douglas to discuss bush doofs, Australian psychedelic commercialization, Entheogenesis Australis, Haridy's new book, and mor...
Ten VA Sites, REMS and Ibogaine’s “Uphill Battle”: Feds Weigh In on Psychedelic Access
At the Psychedelic Healthcare Forum, which took place in New York City last Thursday and was co-hosted by Psychedelic Alpha, a panel of federal officials participated in a discussion moderated by POLI...
Oregon U-turns on Doubling Psilocybin License Fees
Oregon’s health regulators shelved a proposal that would have doubled what psilocybin businesses and facilitators pay for their state licenses.
What Psychedelics Have Taught Me About Paying Attention as a Father
Having a kid is the most psychedelic thing I have ever done. You meet this newborn person who cannot do much of anything, then watch as they learn to move, talk, make jokes, push your buttons and deve...
Psymposia Aesthetics: Team Portrait Illustrations
Russell presents a time-lapse of his illustrations of Psymposia team members James and Mike. A while back he made a series of team illustrations used for YouTube thumbnails.
Weekly Psychedelic Policy Briefing: October 12, 2026
FDA laid out how the first federally funded ibogaine trials could be run, with inpatient cardiac monitoring and a 10 mg/kg starting dose ceiling.
How to Change Your Behavior
From How to Change Your Mind to dueling theories about the neurobiological mechanisms of psychedelics, one thing has become increasingly clear: psychedelic therapy has officially left the shadows of N...
2026 Third Quarter — Legislative Wrap Up
Since the beginning of 2026, at least 23 states have introduced psychedelic legislation, signaling continued momentum and openness in how local and federal leaders address mental health, substance use...
Psychedelic Churches Need Psychedelic Seminaries
The psychedelic field has built institutions for studying molecules, delivering therapies, and training facilitators.
Statement on DEA attempt to reschedule five tryptamines
Last week, the DEA moved to place five little-known psychedelic compounds — 4-OH-DiPT, 5-MeO-AMT, 5-MeO-MiPT, 5-MeO-DET, and DiPT — into Schedule I of the Controlled Substances Act.
The Oldest Ayahuasca Researchers Weren't in Labs
The first World Ayahuasca Forum brought some 1,800 people and dozens of Indigenous peoples to Girona, Catalunya, in northeastern Spain.
By continuing to use this site, you agree to our Terms and Privacy Policy.






